ArticlePlastic and reconstructive surgery. Global open2025
Evaluation of Endoscopic Release for Carpal Tunnel Syndrome.
Article in Plastic and reconstructive surgery. Global open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Carpal tunnel syndrome (CTS) is the most common nerve entrapment disorder of the upper limb worldwide. Endoscopic carpal tunnel release (ECTR) has been widely applied to CTS and has achieved good results. Detailed postoperative outcomes of ERCT at different time points in the Chinese population are rare. Methods: From January 2018 to December 2022, we collected and evaluated information from 186 patients (273 wrists) who received 2-port ECTR in a prospective cohort study. The Boston Carpal Tunnel Questionnaire, the visual analog pain scale, grip strength, pinch strength, the Semmes-Weinstein monofilament test, and 2-point discernment were used to evaluate postoperative recovery at preoperative, 3 weeks, 3 months, 6 months, 9 months, and 12 months postsurgery. We also recorded surgical complications, tenosynovitis, and patient satisfaction. Results: The male-to-female ratio reached 1 to 10.6. The most common age for CTS is 50-59 years (up 52.7%), and the average age was 52.1 years. The Boston Carpal Tunnel Questionnaire functional status scale and symptom severity scale showed significant improvement and lasted up to 12 months postsurgery. The pain was present after surgery and relieved within 6 months. Grip and pinch strength decreased at 3 weeks and recovered at 6 months after the operation. The Semmes-Weinstein monofilament test and 2-point discernment continued to improve and were stable 6 months after surgery. One vascular injury, 1 nerve injury, 10 cases of transient nerve paralysis, and 12 instances of columnar pain were recorded. There were no skin or wound-related complications. No revision carpal tunnel release was required. Ninety-one percent of patients were satisfied. Conclusions: Patients who received ECTR had significant functional and symptom improvements with rare complications. The ECTR is a reliable and acceptable option for CTS.
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.